By contrast, the positive impact of CD44, MKI67 and RUNX2 overexpression on HGSOC patient survival is likely caused by their proliferation-promoting function which, in turn, sensitizes cancer cells with the normal p53 protein to cisplatin and other DNA-damaging agents [20]. The gene discussed is CD44; the disease is cancer.